Background Image
Table of Contents Table of Contents
Previous Page  60 / 76 Next Page
Information
Show Menu
Previous Page 60 / 76 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 6, November/December 2016

390

AFRICA

specifically HbA

1c

level, ambulatory BP and silent ischaemia in a

bi-ethnic gender cohort. Overall, African men showed a poorer

cardiometabolic profile accompanied by lower cortisol levels

when compared to their Caucasian counterparts. Attenuated

cortisol levels therefore seem to act as the driving force in the

cortisol:BDNF ratio and may ultimately down-regulate BDNF.

The novel ratio of cortisol:BDNFmay sustain cardiometabolic

risk and induce neurodegeneration. Cardiometabolic morbidity

further increased in the African men as their reduced coronary

perfusion, as evidenced in the number of 24-hour silent ischaemic

events, would increase BP as a compensatory mechanism to

maintain homeostasis.

Despite the fact that a pre-diabetic state was demonstrated

in the African gender cohort, it was not directly associated with

cortisol:BDNF ratio. In another SABPA sub-study, chronic

hyperglycaemia was shown to facilitate endothelial dysfunction

and susceptibility to stroke risk in the African male cohort.

17

Indeed, Hamer

et al

.

18

also demonstrated associations between

glucose homeostasis as assessed by HbA

1c

concentration and

coronary artery calcification. A hyperglycaemic state therefore

predisposes to cardiometabolic morbidity in the presence of

emotional distress markers such as cortisol:BDNF.

A profile of blunted cortisol and norepinephrine metabolite

responses were associated with structural wall remodelling in a

depressed SABPA African male cohort.

12

The attenuated cortisol

levels of the current African sub-group may therefore support

the notion of increased chronic distress.

19,20

Attenuated BDNF levels in Africans might also induce

decreased neuroplasticity, vulnerability to depression and

cardiovascular risk.

6

In this study, cortisol:BDNF ratio was

associated with silent ischaemia, suggesting possible down-

regulation of BDNF, and implicating a central neural regulatory

role.

10

In animal studies, high concentrations of BDNF in

hypothalamic nuclei and neurons secreting CRF support the

role of BDNF in the stress response.

6

During chronic stress,

a maladaptive cortisol response is elicited due to structural

changes in the HPA axis.

21-23

A state of psychological distress in

Africans may therefore be present.

12,19,20

Indeed, we have confirmed that chronic depression in

the SABPA African teachers’ cohort was associated with

microvascular dysregulation and perfusion deficits.

21

If this

state is further supported by high levels of alcohol abuse,

the central depressant effect of alcohol may disturb central

cardiometabolic homeostasis.

21

Chronic psychological stress

induces sympathetic hyperactivity,

17

higher circulating levels of

catecholamine and cortisol, and ultimately down-regulation

will occur.

12,22-24

Therefore, the lower cortisol level may act as the

driving force behind a possible down-regulated BDNF.

The cortisol:BDNF ratio in African men suggests a

susceptibility to increased cardiometabolic risk. Indeed,

cortisol:BDNF is associated with silent ischaemia in African men

and impairs central autoregulation, explaining the compensatory

increases in blood pressure to maintain homeostasis.

3,14,19

During chronic stress, sympathetic hyperactivity and increased

norepinephrine and cortisol levels will elicit vasoconstrictive

responses and reduce perfusion in the coronary circulation.

12,23

Furthermore, susceptibility to emotional distress as well

as HPA-axis disturbance is enhanced when using defensive

coping mechanisms.

14

Defensive coping facilitated autonomic

dysfunction or sympathetic hyperactivity in the current African

male cohort.

14

This underpins the importance of a central

regulatory control system where higher emotional demands

impact on cardiometabolic health.

Cortisol can further induce or exacerbate down-regulation

of BDNF during chronic stress conditions.

6,10

Lower levels of

BDNF have been associated with depression,

6

and recently

cardiometabolic risk.

10

Down-regulation and the aftermath of

low BDNF levels impair neuroplasticity and homeostasis.

11,13,23,24

With BDNF down-regulation, dysregulation of the HPA axis

may also occur, as both BDNF and cortisol critically impact

on the stress response.

24

This suggests that central neural

control dysregulation enforces a disturbed cortisol:BDNF ratio,

augmenting silent ischaemia and overburdening the heart. This

is the first time this ratio has been reported, and further research

is needed to support the findings and significance.

Susceptibility to emotional distress may be an underlying

factor in the observed differences in the bi-ethnic gender cohort.

We suggest that attenuated cortisol levels may act as the driving

force to downregulate BDNF, increasing cardiometabolic risk

and reducing coronary perfusion during psychological distress.

One limitation of the study is that a very specific population

was studied and results may vary across populations, depending

Table 4. Independent associations between cardiometabolic risk markers,

cortisol as well as cortisol:brain derived neurotrophic factor (BDNF) in an African male cohort

HbA

1c

24-h SBP

24-h DBP

Silent ischaemia

β

(95% CI)

p-

value

β

(95% CI)

p-

value

β

(95% CI)

p-

value

β

(95% CI)

p-

value

Adjusted

R

2

0.16

0.29

0.21

0.12

Cortisol

0.21 (0.0–0.4)

0.04

0.23 (0.1–0.4)

0.01

0.23 (0.1–0.4)

0.01

0.18 (0.0–0.4)

0.07

GGT

0.14 (0.0–0.3)

0.10

0.22 (0.0–0.4)

0.02

Age

0.30 (0.1–0.5)

<

0.01

0.20 (0.0–0.4)

0.04

0.33 (0.1–0.5)

<

0.01

Log physical activity

0.30 (0.1–0.5)

0.02

0.28 (0.0–0.5)

0.08

Body surface area

0.18 (–0.1–0.4)

0.14

0.15 (–0.1–0.4)

0.26

Adjusted

R

2

<

0.10

0.26

0.15

0.22

Cortisol:BDNF

0.20 (0.0–0.4)

0.03

0.40 (0.2–0.6)

<

0.01

Log cGGT

Age

0.32 (0.1–0.5)

<

0.01

0.36 (0.2–0.5)

<

0.01

Log physical activity

0.29 (0.0–0.5)

0.02

0.16 (0.0–0.4)

0.09

Body surface area

0.21 (0.0–0.5)

0.09

HbA

1c,

glycated haemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; log cGGT, log gamma-glutamyl transferase.

Additional covariates included log cotinine levels.